Review
Androgens in women

https://doi.org/10.1016/S0960-0760(03)00204-8Get rights and content

Abstract

The role of androgen treatment in women remains controversial. The proposed “Female Androgen Insufficiency Syndrome” (Fertility and Sterility, April 2002) describes a number of non-specific symptoms including unexplained fatigue, decreased well being/dysphoric mood and/or blunted motivation and diminished sexual function. An estimated 40% of women experience sexual dysfunction, highlighting the need for ongoing research into this field in order to fully define the possible contribution of androgen insufficiency. The increasing availability of products, such as dehydroepiandrosterone (DHEA) supplements also points to the need for controlled studies to assess the safety of these and other preparations.

Measurement of androgens in women requires sensitive assays with the ability to detect low levels and a narrow range with precision. Normal ranges of androgens for women of reproductive and post-reproductive age remain poorly defined. Debate exists as per importance of measurement of free versus total testosterone, with the ‘free androgen index’ offering an alternative method of assessment of testosterone availability.

Testosterone treatment is being developed for women in the form of transdermal patches, gels or cream, with percutaneous implants in common usage in some countries. Recent research has highlighted alternative means of administration, such as oral inhalation or buccal lozenge. DHEA is widely available in some countries. Research to date has demonstrated improvements in libido and sexual function, mood and well being. Evidence points to other potential benefits of androgen treatment, including preservation of bone mass, a possible protective role in breast cancer and beneficial effects on cognition.

Adverse effects of androgen treatment in women are dose-dependent and include virilisation, mood disturbance and acne. These are uncommon if appropriate doses are administered and highlight the need for treatment to be closely monitored clinically and biochemically. Beneficial effects of testosterone treatment in post-menopausal women with lowered androgen levels have been well documented, and preliminary evidence suggests a role for treatment in pre-menopausal women with symptoms and lowered testosterone levels.

References (27)

  • B. Zumoff et al.

    Twenty-four hour mean plasma testosterone concentrations declines with age in normal premenopausal women

    J. Clin. Endocrinol. Metab.

    (1995)
  • H.G. Burger et al.

    A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition

    J. Clin. Endocrinol. Metab.

    (2000)
  • M.R. Jiroutek et al.

    Changes in reproduction hormones and sex hormone-binding globulin in a group of post-menopausal women measured over 10 years

    Menopause

    (1998)
  • Cited by (79)

    • Testing the role of testosterone versus estrogens in mediating reproductive transitions in female rhesus macaques

      2022, Hormones and Behavior
      Citation Excerpt :

      Although androgens are typically known as ‘male’ hormones, they are indispensable for normal development and reproduction in female vertebrates (Staub and De Beer, 1997; Walters, 2015). Via androgen receptor signaling, T plays a key role in the normal reproduction of female primates including women, in addition to actions via conversion to estrogens (Arlt, 2006; Burger, 2002; Davison and Davis, 2003). When androgen production is suppressed by bilateral ovariectomy and adrenalectomy, female rhesus macaques (Macaca mulatta) become sexually unreceptive despite being given estrogen; T then restores receptivity when given subcutaneously (Everitt et al., 1972) or implanted into the central nervous system (Everitt and Herbert, 1975).

    • Testosterone synthesis in the female songbird brain

      2020, Hormones and Behavior
      Citation Excerpt :

      Neuromodulators, including neuroestrogens, are synthesized within the brain to rapidly control local neural circuits and behavior (Remage-Healey, 2014; Saldanha et al., 2011). Testosterone has been suggested to control important functions such as female sexual desire in humans (Alexander et al., 2006; Davison and Davis, 2003, 2011; Pluchino et al., 2013) and women often report an increased sexual desire when they are treated with testosterone (Arlt et al., 1999; Tuiten et al., 2000; Van Goozen et al., 1997) despite concurrent aromatase inhibition (Dahir and Travers-Gustafson, 2014). Cognitive performance has also been linked to androgens in women (Davison and Davis, 2003; Pluchino et al., 2015), and testosterone can affect attention, emotion processing and memory within a few hours of treatment (Aleman et al., 2004; Bos et al., 2016; Postma et al., 2000), consistent with a direct neural site-of-action.

    • Sexual function and depressive symptoms in young women with overt hyperthyroidism

      2019, European Journal of Obstetrics and Gynecology and Reproductive Biology
    • The psychological aspects of female sexuality in the context of Schizophrenia

      2023, A Guide to Clinical Psychology: Psychopathology
    • The handbook of sex differences volume IV identifying universal sex differences

      2023, The Handbook of Sex Differences Volume IV Identifying Universal Sex Differences
    View all citing articles on Scopus

    Presented at the 11th International Congress on Hormonal Steroids and Hormones and Cancer, ICHS & ICHC, Fukuoka, Japan, 21–25 October 2002.

    View full text